{"id":2394,"date":"2019-02-28T00:00:00","date_gmt":"2019-02-28T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2394"},"modified":"2019-02-28T00:00:00","modified_gmt":"2019-02-28T00:00:00","slug":"centogene-oglasza-strategiczna-wspolprace-z-sarepta-theraptics","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/pl\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","title":{"rendered":"CENTOGENE og\u0142asza strategiczn\u0105 wsp\u00f3\u0142prac\u0119 z Sarepta Therapeutics"},"content":{"rendered":"

Firma CENTOGENE og\u0142osi\u0142a dzi\u015b 12-miesi\u0119czn\u0105 strategiczn\u0105 wsp\u00f3\u0142prac\u0119 z Sarepta Therapeutics, Inc.<\/a> (NASDAQ:SRPT) w celu identyfikacji pacjent\u00f3w z dystrofi\u0105 mi\u0119\u015bniow\u0105 Duchenne\u2019a (DMD) w regionie Bliskiego Wschodu i Afryki P\u00f3\u0142nocnej.<\/p>\n

CENTOGENE przeprowadzi pe\u0142n\u0105 diagnostyk\u0119 molekularn\u0105, wykorzystuj\u0105c analiz\u0119 delecji\/duplikacji oraz sekwencjonowanie pe\u0142nej d\u0142ugo\u015bci genu DMD u pacjent\u00f3w z ujemnym wynikiem testu MLPA. Zgodnie z warunkami umowy z firm\u0105 Sarepta, CENTOGENE b\u0119dzie r\u00f3wnie\u017c \u015bwiadczy\u0107 us\u0142ugi diagnostyczne lekarzom lecz\u0105cym pacjent\u00f3w z objawami DMD. Lekarze mog\u0105 przes\u0142a\u0107 pr\u00f3bk\u0119 pacjenta za po\u015brednictwem opatentowanego, zwalidowanego zestawu do pobierania suchej kropli krwi firmy CENTOGENE, wykorzystuj\u0105c niewielk\u0105 ilo\u015b\u0107 krwi.<\/p>\n

\u201cNasza wsp\u00f3\u0142praca z Sarepta Therapeutics jest kolejnym dowodem zaanga\u017cowania firmy CENTOGENE w przyspieszenie rozwoju nowych lek\u00f3w sierocych poprzez wykorzystanie naszej wiedzy o globalnym rynku chor\u00f3b rzadkich \u2013 w szczeg\u00f3lno\u015bci naszego do\u015bwiadczenia w identyfikacji pacjent\u00f3w z DMD\u201d \u2013 skomentowa\u0142 dr Arndt Rolfs, dyrektor generalny i za\u0142o\u017cyciel firmy CENTOGENE. \u201cDzi\u015b, gdy \u015bwiat obchodzi Dzie\u0144 Chor\u00f3b Rzadkich i mierzy si\u0119 z ogromnymi wyzwaniami, z jakimi borykaj\u0105 si\u0119 na co dzie\u0144 osoby \u017cyj\u0105ce z rzadk\u0105 chorob\u0105, niezmiennie d\u0105\u017cymy do przekszta\u0142cania wiedzy genetycznej w rozwi\u0105zania i tworzenia nadziei dla pacjent\u00f3w z chorobami rzadkimi i ich rodzin\u201d.\u201d<\/p>\n

\u201cCelem Sarepta jest zapewnienie lepszego \u017cycia wszystkim kwalifikuj\u0105cym si\u0119 osobom z DMD na ca\u0142ym \u015bwiecie, i zrobienie tego w jak najszybszym terminie. Dzisiejsza umowa z CENTOGENE to krok w kierunku osi\u0105gni\u0119cia tego celu\u201d \u2013 powiedzia\u0142 Doug Ingram, prezes i dyrektor generalny Sarepta.<\/p>\n

DMD to choroba genetyczna dotykaj\u0105ca oko\u0142o 1 na 3500 do 5000 noworodk\u00f3w p\u0142ci m\u0119skiej. Choroba powoduje post\u0119puj\u0105ce os\u0142abienie i zanik mi\u0119\u015bni, a jej przyczyn\u0105 jest niedob\u00f3r dystrofiny, niezb\u0119dnego bia\u0142ka, kt\u00f3re pomaga utrzyma\u0107 kom\u00f3rki mi\u0119\u015bniowe w nienaruszonym stanie. Os\u0142abienie mi\u0119\u015bni staje si\u0119 coraz bardziej zauwa\u017calne w wieku od 3 do 5 lat, a wi\u0119kszo\u015b\u0107 pacjent\u00f3w porusza si\u0119 na w\u00f3zku inwalidzkim w wieku 13 lat, trac\u0105c zdolno\u015b\u0107 chodzenia. W okresie dojrzewania zanik mi\u0119\u015bni sercowych i oddechowych prowadzi do powa\u017cnych, zagra\u017caj\u0105cych \u017cyciu powik\u0142a\u0144.<\/p>","protected":false},"excerpt":{"rendered":"

Firma CENTOGENE og\u0142osi\u0142a dzi\u015b rozpocz\u0119cie 12-miesi\u0119cznej strategicznej wsp\u00f3\u0142pracy z firm\u0105 Sarepta Therapeutics, Inc. w celu identyfikacji pacjent\u00f3w cierpi\u0105cych na dystrofi\u0119 mi\u0119\u015bniow\u0105 Duchenne\u2019a (DMD) w regionie Bliskiego Wschodu i Afryki P\u00f3\u0142nocnej.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2394","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pl\/centogene-oglasza-strategiczna-wspolprace-z-sarepta-theraptics\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CENTOGENE today announced a 12-month strategic collaboration with Sarepta Therapeutics, Inc. for the identification of patients with Duchenne muscular dystrophy (DMD) in the Middle East and North Africa region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pl\/centogene-oglasza-strategiczna-wspolprace-z-sarepta-theraptics\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-28T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics\",\"datePublished\":\"2019-02-28T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\",\"name\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2019-02-28T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pl\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE og\u0142asza strategiczn\u0105 wsp\u00f3\u0142prac\u0119 z Sarepta Therapeutics | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pl\/centogene-oglasza-strategiczna-wspolprace-z-sarepta-theraptics\/","og_locale":"pl_PL","og_type":"article","og_title":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE","og_description":"CENTOGENE today announced a 12-month strategic collaboration with Sarepta Therapeutics, Inc. for the identification of patients with Duchenne muscular dystrophy (DMD) in the Middle East and North Africa region.","og_url":"https:\/\/www.centogene.com\/pl\/centogene-oglasza-strategiczna-wspolprace-z-sarepta-theraptics\/","og_site_name":"CENTOGENE","article_published_time":"2019-02-28T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"admincg","Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics","datePublished":"2019-02-28T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pl-PL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","url":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","name":"CENTOGENE og\u0142asza strategiczn\u0105 wsp\u00f3\u0142prac\u0119 z Sarepta Therapeutics | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2019-02-28T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Kierowanie medycyn\u0105 precyzyjn\u0105","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/pl\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/comments?post=2394"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/media?parent=2394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/categories?post=2394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/tags?post=2394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}